热门资讯> 正文
Acurx Pharmaceuticals GAAP每股收益为-0.28美元,相差0.04美元
2024-05-15 18:51
- Acurx Pharmaceuticals press release (NASDAQ:ACXP): Q1 GAAP EPS of -$0.28 misses by $0.04.
- The company incurred research and development expenses in the amount of $1.56M.
More on Acurx Pharmaceuticals
- Acurx Pharmaceuticals, Inc. (ACXP) Q4 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
- Historical earnings data for Acurx Pharmaceuticals
- Financial information for Acurx Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。